Keyphrases
Jewish Population
100%
Ashkenazi Jews
100%
Retinitis pigmentosa
100%
Population Genetics
100%
Clinical Aspects
100%
Genetic Aspects
100%
Non-syndromic Retinitis pigmentosa
100%
Diphosphate
75%
Visual Acuity
37%
Visual Field
37%
Biallelic
25%
Genetic Causes
25%
Causative Gene
25%
Causative mutation
25%
Pseudo-color
25%
Electroretinography
25%
Autofluorescence
25%
Clinical Examination
12%
Age of Onset
12%
Old Age
12%
Structural Change
12%
Young Age
12%
Inheritance Pattern
12%
Disease-causing mutations
12%
Sanger Sequencing
12%
Clinical Data
12%
Patient Matched
12%
Alu Insertion
12%
Clinical Parameters
12%
Founder mutation
12%
Cell-Associated
12%
Funduscopy
12%
Ophthalmological
12%
Genotype-phenotype Correlation
12%
Autosomal Recessive Inheritance
12%
General Patients
12%
Electrophysiologic
12%
Retinal Function
12%
Retinal Phenotype
12%
Male Germ Cells
12%
Fundus Photography
12%
Retinal Imaging
12%
OCT Imaging
12%
Color Vision Testing
12%
Medicine and Dentistry
Clinical Feature
100%
Retinitis pigmentosa
100%
Synthetase
66%
Pyrophosphate
66%
Visual Acuity
33%
Visual Field
33%
Optical Coherence Tomography
22%
Autofluorescence
22%
Electroretinography
22%
Clinical Examination
11%
Clinical Finding
11%
Cohort Analysis
11%
Autosomal Recessive Inheritance
11%
Ophthalmoscopy
11%
Phosphotransferase
11%
Onset Age
11%
Sanger Sequencing
11%
Vision Test
11%
Color Vision
11%
Fundus Photography
11%
Retinal Imaging
11%
Germ Cell
11%
Diseases
11%
Biochemistry, Genetics and Molecular Biology
Retinitis pigmentosa
100%
Population Genetics
100%
Synthase
66%
Pyrophosphate
66%
Genetics
33%
Visual Field
33%
Visual Acuity
33%
Electroretinography
22%
Autofluorescence
22%
Kinase
11%
Phosphotransferase
11%
Autosomal Recessive Inheritance
11%
Cohort Study
11%
Germ Cell
11%
Color Vision
11%
MAK (Gene)
11%
Dideoxynucleotide Sequencing
11%
Neuroscience
Retinitis pigmentosa
100%
Population Genetics
100%
Pyrophosphate
66%
Synthetase
66%
Autofluorescence
22%
Electroretinography
22%
Kinase
11%
Germ Cell
11%
Ophthalmoscopy
11%
Dideoxynucleotide Sequencing
11%